In this study, we used several serological assays to measure IgA and IgM antibodies levels against the nucleocapsid protein (NCP) at 1 month after symptom onset, and monitored IgG against the RBD in the S1 subunit and anti-N IgG up to 1 year after infection. Here, CD79A is linked to infection.